Open Payments

SCOTT ALAN HACKER

Type
Physician · Allopathic & Osteopathic Physicians / Orthopaedic Surgery / Sports Medicine
Where
LA MESA, CA
NPI
1750450805
Received
$931,437 in 205 records, 2019 to 2025 ($434,027 general, $497,409 research)
As principal investigator
$2,560,898 of research payments to others in 221 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment12$4,388
2025Research payment4$10,391
2024General payment8$513
2024Research payment13$222,622
2023General payment11$9,221
2023Research payment18$264,396
2022General payment27$31,956
2021General payment61$124,658
2020General payment24$137,392
2019General payment27$125,896

By company

CompanyRecordsAmountYears
Heron Therapeutics, Inc.72$328,7132019–2022
Episurf Medical, Inc.25$312,4162023–2025
Aesculap Biologics, LLC18$185,5782019–2023
Anika Therapeutics, Inc.11$61,2332020–2021
Bioventus LLC31$37,3122019–2025
Smith+Nephew, Inc.4$4,0052021–2025
Stryker Corporation23$1,1902019–2025
Elevate Surgical Co2$1712024–2025
Zimmer Biomet Holdings, Inc.2$1582020–2025
ORTHALIGN INC1$1502023
Cartiheal (2009) LTD.1$1232023
BIOTISSUE HOLDINGS INC.1$1032024
Pacira Therapeutics, Inc.3$542021
Ethicon US, LLC2$432024–2025
SANOFI-AVENTIS U.S. LLC2$312019–2023
Merck Sharp & Dohme LLC1$302023
DJO, LLC1$242019
HERAEUS MEDICAL, LLC.1$232022
DePuy Synthes Sales Inc.1$232025
MOXIMED, INC1$182025
Avanos Medical1$172023
PFIZER INC.1$112019

By nature of payment

NatureRecordsAmount
Research payment35$497,409
Consulting Fee69$408,752
Compensation for services other than consulting, including serving as faculty or as a speaker at a v5$17,100
Travel and Lodging21$4,325
Food and Beverage75$3,850

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-19Zimmer Biomet Holdings, Inc.$128Food and BeverageIn-kind items and servicesAvenir Device, Hips2025
2025-10-24Stryker Corporation$56Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2025
2025-10-02Episurf Medical, Inc.$4,390Research paymentCash or cash equivalentEpis Knee Trial2025
2025-09-02MOXIMED, INC$18Food and BeverageIn-kind items and servicesMISHA KNEE SYSTEM, SMALL, LEFT Device, ORTHOPEDICS2025
2025-08-07Episurf Medical, Inc.$2,530Research paymentCash or cash equivalentEpis Knee Trial2025
2025-07-31Bioventus LLC$34Food and BeverageIn-kind items and servicesXCELL Device, DEVICES2025
2025-06-04Elevate Surgical Co$23Food and BeverageIn-kind items and services2025
2025-05-22Smith+Nephew, Inc.$55Food and BeverageIn-kind items and servicesKatalyst Bipolar Radial Head System Device, Extremity, Upper2025
2025-05-19DePuy Synthes Sales Inc.$23Food and BeverageIn-kind items and servicesINTRAFIX Device, Sports Surgical2025
2025-05-02Episurf Medical, Inc.$1,265Research paymentCash or cash equivalentEpic Knee Trial2025
2025-04-23Stryker Corporation$23Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2025
2025-04-02Ethicon US, LLC$17Food and BeverageIn-kind items and servicesSTRATAFIX Device, Wound Closure2025
2025-03-06Episurf Medical, Inc.$2,206Research paymentCash or cash equivalentEpic Knee Trial2025
2025-02-27Smith+Nephew, Inc.$3,900Consulting FeeCash or cash equivalent2025
2025-02-18Stryker Corporation$71Food and BeverageIn-kind items and servicesGAMMA Device, TRAUMA & EXTREMETIES2025
2025-01-15Bioventus LLC$36Food and BeverageIn-kind items and servicesSUPARTZ FX SODIUM HYALURONATE Device, DEVICES2025
2024-12-11Stryker Corporation$24Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2024
2024-12-09Episurf Medical, Inc.$3,303Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-10-30Episurf Medical, Inc.$3,383Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-10-02Episurf Medical, Inc.$17,330Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-10-02Elevate Surgical Co$147Food and BeverageIn-kind items and services2024
2024-09-16BIOTISSUE HOLDINGS INC.$103Food and BeverageCash or cash equivalent2024
2024-09-10Episurf Medical, Inc.$21,048Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-09-05Ethicon US, LLC$25Food and BeverageIn-kind items and servicesETHICON Device, Biosurgical2024
2024-08-01Episurf Medical, Inc.$11,894Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-07-02Episurf Medical, Inc.$37,034Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-06-13Stryker Corporation$104Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2024
2024-06-10Episurf Medical, Inc.$40,895Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-05-02Episurf Medical, Inc.$13,489Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-04-21Smith+Nephew, Inc.$34Food and BeverageIn-kind items and servicesPanta 2 Device, Extremity, Lower Plates, Screws, and Nails2024
2024-04-18Stryker Corporation$40Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2024
2024-04-03Episurf Medical, Inc.$18,664Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-03-08Episurf Medical, Inc.$4,480Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-02-06Stryker Corporation$32Food and BeverageIn-kind items and servicesTRIATHLON Device, KNEES2024
2024-02-01Episurf Medical, Inc.$35,642Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-01-03Episurf Medical, Inc.$8,760Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2024-01-03Episurf Medical, Inc.$6,700Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2024
2023-11-08Avanos Medical$17Food and BeverageIn-kind items and servicesTRIVISC SODIUM HYALURONATE Device, PAIN MANAGEMENT2023
2023-10-27Episurf Medical, Inc.$2,400Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-10-06Episurf Medical, Inc.$11,089Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-10-05Stryker Corporation$60Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2023
2023-10-04Aesculap Biologics, LLC$15,014Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-09-11Episurf Medical, Inc.$1,989Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-08-23Aesculap Biologics, LLC$4,556Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-08-14ORTHALIGN INC$150Food and BeverageCash or cash equivalentORTHALIGN PLUS Device, ORTHOPEDIC SURGERY2023
2023-08-09Aesculap Biologics, LLC$28,839Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-08-09Episurf Medical, Inc.$18,226Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-08-02Stryker Corporation$23Food and BeverageIn-kind items and services1688 Device, VISUALIZATION2023
2023-07-27Cartiheal (2009) LTD.$123Food and BeverageIn-kind items and servicesAgili-C Device, Sports Med Knee2023
2023-07-10Episurf Medical, Inc.$13,980Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-07-05Aesculap Biologics, LLC$14,687Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-06-14SANOFI-AVENTIS U.S. LLC$14Food and BeverageIn-kind items and servicesSYNVISC-ONE Device, Orthopedics/Orthopedic Surgery2023
2023-06-09Episurf Medical, Inc.$5,293Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-06-06Bioventus LLC$1,600Consulting FeeCash or cash equivalent2023
2023-05-30Merck Sharp & Dohme LLC$30Food and BeverageIn-kind items and servicesBRIDION Drug, NEUROSCIENCE2023
2023-05-24Aesculap Biologics, LLC$11,497Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-05-02Episurf Medical, Inc.$23,076Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-04-26Aesculap Biologics, LLC$29,126Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-03-15Episurf Medical, Inc.$3,350Research paymentCash or cash equivalentEPIC-Knee Episealer Knee System IDE Clinical Study2023
2023-03-01Aesculap Biologics, LLC$32,942Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-02-01Aesculap Biologics, LLC$19,001Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-02-01Aesculap Biologics, LLC$21Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-01-06Bioventus LLC$4,800Consulting FeeCash or cash equivalent2023
2023-01-06Bioventus LLC$1,600Consulting FeeCash or cash equivalent2023
2023-01-06Bioventus LLC$800Consulting FeeCash or cash equivalent2023
2023-01-04Aesculap Biologics, LLC$29,305Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2022-10-26Bioventus LLC$1,631Consulting FeeCash or cash equivalent2022
2022-09-29Bioventus LLC$700Consulting FeeCash or cash equivalent2022
2022-08-27Aesculap Biologics, LLC$71Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2022
2022-08-17Bioventus LLC$700Consulting FeeCash or cash equivalent2022
2022-07-20Stryker Corporation$27Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2022
2022-07-07Bioventus LLC$8,225Consulting FeeCash or cash equivalent2022
2022-07-07Bioventus LLC$5,425Consulting FeeCash or cash equivalent2022
2022-07-07Bioventus LLC$4,987Consulting FeeCash or cash equivalent2022
2022-07-07Bioventus LLC$815Travel and LodgingCash or cash equivalent2022
2022-07-07Bioventus LLC$42Travel and LodgingCash or cash equivalent2022
2022-07-07Bioventus LLC$38Travel and LodgingCash or cash equivalent2022
2022-07-07Bioventus LLC$35Travel and LodgingCash or cash equivalent2022
2022-07-07Bioventus LLC$35Travel and LodgingCash or cash equivalent2022
2022-07-07Bioventus LLC$30Travel and LodgingCash or cash equivalent2022
2022-07-07Bioventus LLC$25Food and BeverageCash or cash equivalent2022
2022-05-15Bioventus LLC$46Food and BeverageIn-kind items and services2022
2022-05-13Bioventus LLC$99Food and BeverageIn-kind items and services2022
2022-05-11Bioventus LLC$2,800Consulting FeeCash or cash equivalent2022
2022-05-11HERAEUS MEDICAL, LLC.$23Food and BeverageIn-kind items and servicesPALACOS Device, BONE CEMENT2022
2022-05-11Aesculap Biologics, LLC$14Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2022
2022-03-23Heron Therapeutics, Inc.$250Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2022
2022-02-25Aesculap Biologics, LLC$116Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2022
2022-02-17Bioventus LLC$377Travel and LodgingIn-kind items and servicesOther Device, Not Applicable2022
2022-02-17Bioventus LLC$79Travel and LodgingIn-kind items and servicesOther Device, Not Applicable2022
2022-02-17Bioventus LLC$79Travel and LodgingIn-kind items and servicesOther Device, Not Applicable2022
2022-02-16Stryker Corporation$31Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2022
2022-02-15Heron Therapeutics, Inc.$5,250Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2022
2021-12-21Anika Therapeutics, Inc.$2,225Consulting FeeCash or cash equivalent2021
2021-12-10Anika Therapeutics, Inc.$10,385Consulting FeeCash or cash equivalent2021
2021-11-18Heron Therapeutics, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-11-18Heron Therapeutics, Inc.$564Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-11-18Heron Therapeutics, Inc.$417Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-11-18Heron Therapeutics, Inc.$122Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-10-14Anika Therapeutics, Inc.$4,950Consulting FeeCash or cash equivalent2021
2021-10-13Bioventus LLC$24Food and BeverageIn-kind items and servicesGELSYN-3 Device, Not Applicable2021
2021-10-12Bioventus LLC$700Consulting FeeCash or cash equivalent2021
2021-10-08Anika Therapeutics, Inc.$709Consulting FeeCash or cash equivalent2021
2021-10-05Stryker Corporation$34Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2021
2021-09-30Heron Therapeutics, Inc.$2,850Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-09-30Heron Therapeutics, Inc.$313Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-30Heron Therapeutics, Inc.$125Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-30Heron Therapeutics, Inc.$67Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$540Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$182Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$131Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$125Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$27Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$16Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$16Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$5Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-29Heron Therapeutics, Inc.$2Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-09-15Pacira Therapeutics, Inc.$18Food and BeverageIn-kind items and servicesZilretta Drug, Musculoskeletal2021
2021-09-03Stryker Corporation$52Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2021
2021-08-31Stryker Corporation$46Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2021
2021-08-23Aesculap Biologics, LLC$105Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2021
2021-08-16Bioventus LLC$1,400Consulting FeeCash or cash equivalent2021
2021-07-13Stryker Corporation$46Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2021
2021-07-01Heron Therapeutics, Inc.$9,625Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-06-30Stryker Corporation$65Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2021
2021-06-28Pacira Therapeutics, Inc.$18Food and BeverageIn-kind items and servicesZilretta Drug, Musculoskeletal2021
2021-06-23Heron Therapeutics, Inc.$8,125Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-06-23Heron Therapeutics, Inc.$282Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-06-23Heron Therapeutics, Inc.$144Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-06-23Heron Therapeutics, Inc.$139Travel and LodgingIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-06-15Heron Therapeutics, Inc.$1,425Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-06-10Anika Therapeutics, Inc.$709Consulting FeeCash or cash equivalent2021
2021-06-01Heron Therapeutics, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-06-01Heron Therapeutics, Inc.$30Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-05-30Heron Therapeutics, Inc.$33Food and BeverageIn-kind items and servicesZynrelef Drug, Postoperative Pain2021
2021-05-27Heron Therapeutics, Inc.$250Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-05-26Heron Therapeutics, Inc.$19,500Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-05-26Heron Therapeutics, Inc.$1,000Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-05-25Heron Therapeutics, Inc.$6,750Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-05-20Aesculap Biologics, LLC$117Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2021
2021-04-28Bioventus LLC$23Food and BeverageIn-kind items and servicesDurolane Device, Orthopedics/Orthopedic Surgery2021
2021-04-22Heron Therapeutics, Inc.$3,625Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-04-20Stryker Corporation$50Food and BeverageIn-kind items and servicesMAKO Device, KNEES, HIPS2021
2021-04-15Anika Therapeutics, Inc.$1,447Consulting FeeCash or cash equivalent2021
2021-03-26Heron Therapeutics, Inc.$3,125Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-03-19Stryker Corporation$40Food and BeverageIn-kind items and servicesRESTORATION Device, HIPS2021
2021-03-17Smith+Nephew, Inc.$16Food and BeverageIn-kind items and servicesEVOS Device, Trauma Plates, Screws, and Nails2021
2021-03-09Stryker Corporation$7Food and BeverageIn-kind items and servicesTRITANIUM Device, HIPS2021
2021-02-09Pacira Therapeutics, Inc.$17Food and BeverageIn-kind items and servicesZilretta Drug, Musculoskeletal2021
2021-02-03Anika Therapeutics, Inc.$16,558Consulting FeeCash or cash equivalent2021
2021-01-21Heron Therapeutics, Inc.$2,125Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-01-07Heron Therapeutics, Inc.$8,000Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2021-01-07Heron Therapeutics, Inc.$2,375Consulting FeeCash or cash equivalentZynrelef Drug, Postoperative Pain2021
2020-12-04Anika Therapeutics, Inc.$1,269Consulting FeeCash or cash equivalentHyalofast Device, Musculoskeletal2020
2020-11-24Heron Therapeutics, Inc.$2,250Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-11-05Anika Therapeutics, Inc.$2,345Consulting FeeCash or cash equivalentHyalofast Device, Musculoskeletal2020
2020-10-23Heron Therapeutics, Inc.$3,875Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-10-15Stryker Corporation$17Food and BeverageCash or cash equivalentTRIATHLON Device, KNEES2020
2020-10-05Heron Therapeutics, Inc.$2,625Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-10-02Anika Therapeutics, Inc.$14,336Consulting FeeCash or cash equivalentHyalofast Device, Musculoskeletal2020
2020-10-02Heron Therapeutics, Inc.$250Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-09-21Heron Therapeutics, Inc.$17,375Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-09-21Heron Therapeutics, Inc.$2,250Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-08-03Heron Therapeutics, Inc.$4,125Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-08-03Heron Therapeutics, Inc.$1,125Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-06-29Heron Therapeutics, Inc.$19,875Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-06-29Heron Therapeutics, Inc.$1,875Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-04-28Heron Therapeutics, Inc.$23,325Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-04-13Heron Therapeutics, Inc.$500Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-03-11Stryker Corporation$61Food and BeverageCash or cash equivalentMAKO Device, KNEES, HIPS2020
2020-03-11Zimmer Biomet Holdings, Inc.$29Food and BeverageIn-kind items and servicesEBI Bone Healing System Device, Bone Healing2020
2020-03-05Heron Therapeutics, Inc.$22,975Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-03-05Heron Therapeutics, Inc.$4,125Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-03-05Heron Therapeutics, Inc.$3,250Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-03-01Heron Therapeutics, Inc.$3,125Consulting FeeCash or cash equivalentHTX-011 Drug2020
2020-02-26Anika Therapeutics, Inc.$6,300Consulting FeeCash or cash equivalentHyalofast Device, Musculoskeletal2020
2020-02-04Bioventus LLC$107Food and BeverageIn-kind items and services2020
2019-12-13Heron Therapeutics, Inc.$4,250Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-11-21Heron Therapeutics, Inc.$3,750Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-11-15Heron Therapeutics, Inc.$5,000Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-10-30SANOFI-AVENTIS U.S. LLC$16Food and BeverageIn-kind items and servicesSYNVISC-ONE Device, OSTEOARTHRITIS2019
2019-10-10PFIZER INC.$11Food and BeverageIn-kind items and servicesELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE2019
2019-09-28Heron Therapeutics, Inc.$42Food and BeverageIn-kind items and servicesHTX-011 Drug2019
2019-09-28Heron Therapeutics, Inc.$25Food and BeverageIn-kind items and servicesHTX-011 Drug2019
2019-09-28Heron Therapeutics, Inc.$7Food and BeverageIn-kind items and servicesHTX-011 Drug2019
2019-09-25Heron Therapeutics, Inc.$10,125Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-09-16Heron Therapeutics, Inc.$17,500Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-09-13Heron Therapeutics, Inc.$1,000Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-09-13Heron Therapeutics, Inc.$750Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-09-04DJO, LLC$24Food and BeverageIn-kind items and servicesCMF OL1000 Device, Osteogenesis Stimulators2019
2019-08-14Heron Therapeutics, Inc.$6,625Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-07-24Heron Therapeutics, Inc.$5,125Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-07-19Aesculap Biologics, LLC$12Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2019
2019-07-18Aesculap Biologics, LLC$133Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2019
2019-06-10Heron Therapeutics, Inc.$4,125Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-05-17Heron Therapeutics, Inc.$21,625Consulting FeeCash or cash equivalentHTX-011 Drug2019
2019-05-09Stryker Corporation$119Food and BeverageCash or cash equivalentTRIATHLON Device, KNEES2019
2019-05-08Bioventus LLC$14Food and BeverageIn-kind items and servicesSupartz Device, Not Applicable2019
2019-04-25Aesculap Biologics, LLC$14Food and BeverageCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION2019

The latest 200 records of 205.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-11-05Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$10,000A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for 2025
2025-10-06BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$32,650TTAX03-CR0052025
2025-09-23Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$596A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for 2025
2025-08-26Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$3,466A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for 2025
2025-05-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$16,719TTAX03-CR0052025
2025-04-08BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$4,140TTAX03-CR0052025
2025-03-05BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$4,800TTAX03-CR0052025
2025-03-05BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$6,000TTAX03-CR0052025
2025-03-05BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$11,400TTAX03-CR0052025
2025-03-05BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$15,600TTAX03-CR0052025
2025-03-05BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$17,849TTAX03-CR0052025
2025-03-04Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$4,300A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for 2025
2025-02-18Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$8,125A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-blinded Study Investigating the Efficacy, Safety2025
2025-02-10Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$5,656A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-blinded Study Investigating the Efficacy, Safety2025
2025-01-30Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$7,062A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficac2025
2025-01-28Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$35,315A Randomized, Four-arm, Placebo-controlled, Participant, Investigator and Sponsor-blinded Study Investigating the Safety2025
2025-01-22Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$334A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for 2025
2025-01-15Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$16A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficac2025
2024-12-16Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$5,840A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2024
2024-11-15Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$3,640A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2024
2024-11-05BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$2,713TTAX03-CR0052024
2024-10-07BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$1,105TTAX03-CR0052024
2024-10-01Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$16,000A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-blinded Study Investigating the Efficacy, Safety2024
2024-09-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$6,600TTAX03-CR0052024
2024-09-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$9,687TTAX03-CR0052024
2024-08-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$6,600TTAX03-CR0052024
2024-08-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$9,419TTAX03-CR0052024
2024-08-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$1,200TTAX03-CR0052024
2024-08-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$28,800TTAX03-CR0052024
2024-07-17Aesculap Biologics, LLCHORIZON CLINICAL RESEARCH INC$8,857NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2024
2024-07-10BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$8,368TTAX03-CR0052024
2024-07-09Anika Therapeutics, Inc.HORIZON CLINICAL RESEARCH$6,205A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority2024
2024-06-20Aesculap Biologics, LLCHORIZON CLINICAL RESEARCH INC$12,428NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2024
2024-06-13Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$24,380A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficac2024
2024-06-11BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$3,679TTAX03-CR0052024
2024-06-11BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$6,000TTAX03-CR0052024
2024-05-31Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$910A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2024
2024-05-22Aesculap Biologics, LLCHORIZON CLINICAL RESEARCH INC$9,644NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2024
2024-05-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$8,741TTAX03-CR0052024
2024-04-17Aesculap Biologics, LLCHORIZON CLINICAL RESEARCH INC$5,505NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2024
2024-04-10BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$18,284TTAX03-CR0052024
2024-04-08Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$365A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-blinded Study Investigating the Efficacy, Safety2024
2024-03-15Aesculap Biologics, LLCHORIZON CLINICAL RESEARCH INC$5,275NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2024
2024-03-12BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$4,800TTAX03-CR0052024
2024-03-12BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$4,800TTAX03-CR0052024
2024-03-12BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$9,000TTAX03-CR0052024
2024-03-12BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$31,387TTAX03-CR0052024
2024-03-12BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$4,800TTAX03-CR0052024
2024-03-12BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$4,800TTAX03-CR0052024
2024-03-12BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$4,800TTAX03-CR0052024
2024-03-04Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$100A Randomized, Four-arm, Placebo-controlled, Participant, Investigator and Sponsor-blinded Study Investigating the Safety2024
2024-02-21Aesculap Biologics, LLCHORIZON CLINICAL RESEARCH INC$10,129NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2024
2024-02-12Anika Therapeutics, Inc.HORIZON CLINICAL RESEARCH$2,298A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority2024
2024-02-09BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$34,986TTAX03-CR0052024
2024-02-02Smith+Nephew, Inc.HORIZON CLINICAL RESEARCH$1,690A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2024
2024-01-31Aesculap Biologics, LLCHORIZON CLINICAL RESEARCH INC$10,161NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2024
2024-01-15Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$104,605A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficac2024
2024-01-10BIOTISSUE HOLDINGS INC.HORIZON CLINICAL RESEARCH$32,566TTAX03-CR0052024
2024-01-03Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$26,395A Randomized, Four-arm, Placebo-controlled, Participant, Investigator and Sponsor-blinded Study Investigating the Safety2024
2023-11-09Anika Therapeutics, Inc.HORIZON CLINICAL RESEARCH$1,800A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority2023
2023-10-25Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$1,000A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF EN3835 FOR THE TREATMENT OF ADHESIVE 2023
2023-10-23Cartiheal (2009) LTD.HORIZON CLINICAL RESEARCH$910A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2023
2023-10-16Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$7,500A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficac2023
2023-10-12Anika Therapeutics, Inc.HORIZON CLINICAL RESEARCH$921A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority2023
2023-09-25Cartiheal (2009) LTD.HORIZON CLINICAL RESEARCH$1,820A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2023
2023-09-20Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$1,500Observational, Investigator blinded, Long-Term Post-injection Study to Evaluate the Safety and Durability (Efficacy) of 2023
2023-09-13Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$500Observational, Investigator blinded, Long-Term Post-injection Study to Evaluate the Safety and Durability (Efficacy) of 2023
2023-08-03Cartiheal (2009) LTD.HORIZON CLINICAL RESEARCH$910A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2023
2023-08-03Cartiheal (2009) LTD.HORIZON CLINICAL RESEARCH$1,820A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2023
2023-07-14Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$763A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficac2023
2023-06-07Cartiheal (2009) LTD.HORIZON CLINICAL RESEARCH$1,820A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for t2023
2023-04-03Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$38,591A randomized placebo controlled patient and investigator blinded Proof of Concept study investigating the safety tolerab2023
2023-03-22Aesculap Biologics, LLCSAN DIEGO STATE UNIVERSITY$4,725NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-03-15Novartis Pharmaceuticals CorporationSCOTT A HACKER MD MEDICAL CORPORATI HORIZON CLINICAL RESEARCH$78,947A Randomized, Four-arm, Placebo-controlled, Participant, Investigator and Sponsor-blinded Study Investigating the Safety2023
2023-02-22Aesculap Biologics, LLCSAN DIEGO STATE UNIVERSITY$1,574NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2023
2023-02-17Anika Therapeutics, Inc.HORIZON CLINICAL RESEARCH$2,898A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority2023
2023-01-25Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$1,300Observational, Investigator blinded, Long-Term Post-injection Study to Evaluate the Safety and Durability (Efficacy) of 2023
2023-01-24Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$281,481A Randomized, Four-arm, Placebo-controlled, Participant, Investigator and Sponsor-blinded Study Investigating the Safety2023
2022-11-16Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$6,000A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF EN3835 FOR THE TREATMENT OF ADHESIVE 2022
2022-11-09Aesculap Biologics, LLCSCOTT HACKER MD MEDICAL CORP$11,609NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-11-03Bioventus LLCHORIZON CLINICAL RESEARCH$4,930Agili-C Post Approval2022
2022-10-26Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$3,200A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF EN3835 FOR THE TREATMENT OF ADHESIVE 2022
2022-10-19Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$14,400Observational, Investigator blinded, Long-Term Post-injection Study to Evaluate the Safety and Durability (Efficacy) of 2022
2022-10-19Aesculap Biologics, LLCSCOTT HACKER MD MEDICAL CORP$31,366NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-10-05Aesculap Biologics, LLCSCOTT HACKER MD MEDICAL CORP$33,158NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-09-30Bioventus LLCHORIZON CLINICAL RESEARCH$910Agili-C Post Approval2022
2022-09-22Anika Therapeutics, Inc.HORIZON CLINICAL RESEARCH$500A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority2022
2022-08-24Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$3,550Observational, Investigator blinded, Long-Term Post-injection Study to Evaluate the Safety and Durability (Efficacy) of 2022
2022-08-17Bioventus LLCHORIZON CLINICAL RESEARCH$375Agili-C Post Approval2022
2022-08-03Aesculap Biologics, LLCSCOTT HACKER MD MEDICAL CORP$38,056NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-07-12Aesculap Biologics, LLCWestern Institutional Review Board$1,760NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-07-12Aesculap Biologics, LLCWestern Institutional Review Board$560NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-07-12Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$5,050Observational, Investigator blinded, Long-Term Post-injection Study to Evaluate the Safety and Durability (Efficacy) of 2022
2022-07-07Bioventus LLCHORIZON CLINICAL RESEARCH$5,330Agili-C Post Approval2022
2022-06-29Aesculap Biologics, LLCSCOTT HACKER MD MEDICAL CORP$18,999NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-06-28Novartis Pharmaceuticals CorporationHORIZON CLINICAL RESEARCH$2,387A RANDOMIZED, FOUR-ARM, PLACEBO-CONTROLLED, PARTICIPANT, INVESTIGATOR AND SPONSOR-BLINDED STUDY INVESTIGATING THE SAFETY2022
2022-06-22Aesculap Biologics, LLCSAN DIEGO STATE UNIVERSITY$6,300NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2022
2022-06-16Bioventus LLCHORIZON CLINICAL RESEARCH$910Agili-C Post Approval2022
2022-06-15Aesculap Biologics, LLCWestern Institutional Review Board$1,315SAFETY AND EFFICACY OF NOVOCART 3D IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS FOLLOWING FAILURE ON MICROFRACTURE2022
2022-06-14Endo Pharmaceuticals Inc.HORIZON CLINICAL RESEARCH$3,550Observational, Investigator blinded, Long-Term Post-injection Study to Evaluate the Safety and Durability (Efficacy) of 2022

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

San Diego CountyLa Mesa city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In La Mesa, CA, county San Diego County, CA, state California; placed by its city name.

MeasurePlace (city or town)
La Mesa, CA
County
San Diego County, CA
State
California
Population B0100360,7973,288,77439,287,377
Population, 2020 census P161,1213,298,63439,538,223
Median age B0100237.437.337.9
Under 18 B0100121.7%20.9%22.0%
65 and over B0100115.5%15.4%15.7%
Households B1100125,0381,171,27813,548,091
Foreign born B0500213.1%22.8%27.0%
Median household income B19013$95,028$106,268$99,122
Median family income B19113$117,152$122,377$113,346
Per capita income B19301$49,543$51,976$49,513
Poverty rate B1700111.5%10.3%12.0%
Unemployment rate B230256.2%6.1%6.6%
Civilian labor force B2302532,4081,689,38420,068,466
Mean commute (minutes) B0801323.825.528.7
Bachelor's degree or higher B1500340.6%43.2%37.1%
Housing units B2500126,2121,250,64114,644,735
Owner-occupied B2500347.7%54.6%55.9%
Renters B2500352.3%45.4%44.1%
Median home value B25077$812,000$854,700$734,700
Median gross rent B25064$2,049$2,246$2,036
White, not Hispanic B0300250.8%42.4%33.8%
Black B030027.7%4.4%5.2%
Hispanic or Latino B0300227.9%34.6%40.2%
Asian B030025.9%12.1%15.3%
American Indian and Alaska Native B030020.1%0.2%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in La Mesa, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.